Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of ampicillin and gentamicin is a well-documented synergistic antibiotic therapy, primarily used for treating various bacterial infections such as pediatric sepsis and obstructive pyelonephritis. Ampicillin is a semi-synthetic penicillin derivative that functions as a broad-spectrum antibiotic by inhibiting bacterial cell wall synthesis. Gentamicin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis, primarily effective against gram-negative organisms. The synergistic effect of ampicillin and gentamicin makes them more effective together than individually, leading to high survival rates in pediatric sepsis (96%) and effective sterilization of infected kidneys in obstructive pyelonephritis. While zinc is known for its immune-modulating properties and is sometimes used as a supplement in infectious disease management, its specific combination with ampicillin and gentamicin is not directly mentioned in the provided search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ampicillin + Gentamicin + Zinc.